This announcement is a separate document:
6-K: Update on Adjuvant Br.31 Phase III Trial of Imfinzi in Non-small Cell Lung Cancer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.